TNF and neoplasm: In a recent study by our laboratory, a novel nanomedicine carrying recombinant human tumor necrosis factor-alpha (TNF-α) was developed that can be effectively used to reduce tumor IFP to increase paclitaxel delivery and anti-tumor efficacy [70].